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Abstract
Purpose Transforaminal endoscopic discectomy (TED)
minimises paraspinal muscle damage. The aim of this trial
was to compare clinical outcomes of TED to Microdis-
cectomy (Micro).
Methods 143 patients, age 25–70 years and\115 kg, with
single level lumbar prolapse and radiculopathy, were
recruited and randomised. 70 received TED under con-
scious sedation and 70 Micro under general anaesthesia.
Oswestry Disability Index (ODI), visual analogue scores
(VAS) of back and leg pain, and Short Form Health Survey
indices (SF-36) were measured preoperatively and at 3, 12
and 24 months.
Results All outcome measures improved significantly in
both groups (p\ 0.001). Affected side leg pain was lower
in the TED group at 2 years (1.9 ± 2.6 vs 3.5 ± 3.1,
p = 0.002). Hospital stay was shorter following TED
(0.7 ± 0.7 vs 1.4 ± 1.3 days, p\ 0.001). Two Micro
patients and five TED patients required revision giving a
relative risk of revision for TED of 2.62 (95% CI
0.49–14.0).
Conclusions Functional improvements were maintained at
2 years in both groups with less ongoing sciatica after
TED. A greater revision rate after TED was offset by a
more rapid recovery.
Keywords Lumbar discectomy  Microdiscectomy 
Transforaminal endoscopic surgery  Randomised
controlled trial
Introduction
Open spinal surgery comes at a cost of approach related
morbidity. The importance of reducing muscle damage,
particularly to the multifidus muscle that maintains seg-
mental stability, has become well-recognised [1]. The
concept that less aggressive decompression may yield
better results has led to the development of minimally
invasive techniques with microdiscectomy becoming
commonplace in most centres.
In 1990, Kambin highlighted the potential access to the
lumbar disc via the ‘safe-working’ zone or ‘Kambin tri-
angle’ [2]. This precipitated interest in the transforaminal
approach to the disc from within the canal [3–5], as an
alternative to minimally invasive central nucleotomies
(blind percutaneous endoscopic, automated percutaneous
and laser discectomy) that lacked evidence of efficacy [6].
The ability to safely resect disc tissue by this method from
inside the disc out [7], or outside in [8, 9], has been
recognised. Whether the theoretical advantages of trans-
foraminal endoscopic (TED) surgery for symptomatic
lumbar disc herniation are borne out by patient outcomes
remains unclear. A systematic review has highlighted a
paucity of evidence for the TED technique [9], in com-
parison to data now available in respect of microendo-
scopic approaches [10, 11]. In view of the increasing use of
transforaminal approaches to the spine, there is clearly a
need for high-quality randomised controlled trials (RCTs)
to determine whether TED is as effective as traditional
microdiscectomy.
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Patients and methods
The aim of this prospective randomised controlled trial was
to determine whether TED leads to equivalent, better or
worse outcomes than the current ‘gold standard’ of
microdiscectomy. A power sensitivity analysis suggested
140 patients were needed to detect a 10% difference in
Oswestry Disability Index (ODI) improvement at 5% sig-
nificance, with 80% power and 10% loss to follow-up.
Ethical approval was obtained and the study protocol
published (http://www.controlled-trials.com/ISRCTN1155
6571).
The inclusion criteria were: age 25–70, a single level
prolapse with exiting and/or traversing nerve root com-
pression and failure of conservative management
([6 weeks of physiotherapy). Exclusion criteria were:
upper lumbar disc disease (L2/3 or above), previous disc
prolapse, massive sequestered disc prolapse, weight
[115 kg, and malignancy.
Randomisation
All patients were randomised one week before surgery to
receive either TED or Micro, by an off-site secretary using
a random number generating computer program (block
randomisation with odd numbers to TED and evens to
Micro) [12]. This individual had no other involvement with
the trial.
Surgical procedures
All TED were performed using a standardised trans-
foraminal approach and ‘outside-in’ surgical technique
using the TESSYSTM system (joimax GmbH, Germany) as
previously described by Gibson et al. [9]. All surgery was
performed or supervised by a senior spine surgeon with
1-year prior experience of TED and 25 years of experience
with Micro. Patients were treated in the lateral position
with the operating table ‘broken’ at the level of the affected
disc. Conscious ‘analgo-sedation’ was administered as
described by Godschalx [13]. Cannulae and endoscope
placements were monitored using orthogonal bi-planar
imaging (AP and lateral) with an image intensifier. No
intra-operative discography was performed to outline the
disc (to prevent possible internal disc fragmentation). After
identification of the exiting root, pedicle and disc margin,
all prolapsed material was excised using endoscopic ron-
geurs and a powered resector (Shrill, joimax GmbH)
ensuring that both the exiting and traversing roots lay free.
Haemostasis was secured using a radiofrequency probe
(Vaporflex joimax GmbH/Surgimax, UK) with
*0.02 mm penetration depth. Direct entry into the disc
was avoided unless a central herniation was present.
Proximal or distal disc material was accessed by angled
graspers and cannula manipulation.
Microdiscectomy was performed using a standardised
technique under general anaesthesia (GA). The ligamentum
flavum was divided and the traversing nerve root identified
and retracted under magnification (Zeiss, UK). Only pro-
lapsed material was excised unless a fragment was herni-
ating through the outer annulus in which case the disc was
irrigated after prolapse extraction to ensure no sequestered
fragments remained. Loose fragments underlying the pos-
terior longitudinal ligament or extending into the exit
foramen were cleared. A small (\0.75 cm) piece of
absorbable haemostatic gelatin sponge (SpongostanTM,
Ferrosan, Dk) was laid against the dura. No fat graft was
inserted.
Immediate postoperative rehabilitation was identical for
both treatment arms with a minimum of 2 h of bed rest
before mobilisation. Patients were discharged home when
comfortable and at two weeks postoperatively were
allowed to drive, swim and return to work. Physiotherapy
was offered if stiffness was present.
Outcome assessments
Patient reported outcome measures (PROMS) were col-
lected prior to surgery and at 3, 12 and 24 months,
postoperatively. The Oswestry Disability Index (ODI,
version 2a) [14] was applied and back and leg pain
scored on horizontal visual analogue scales (VAS) [15].
General health was assessed using the Short Form SF-36
[16]. Patient satisfaction was assessed using Odom cri-
teria [17]. SF-36 scores were converted into SF-6D
scores [18] (a validated measure of health-related quality
of life that can be used as an alternative to the EQ-5D)
to calculate quality adjusted life years (QALYs) [19]. A
change from baseline approach was implemented using
preoperative and 2 year SF-6D scores. Life expectancy
was assumed as 77.0 years for men and 81.4 years for
women based on regional life expectancy (NHS Lothian
region, Life Expectancy for Areas of Scotland
2008–2010). Time spent in the new health state was
calculated as life expectancy minus age at surgery and
was multiplied by the individual improvement in SF-6D
score to calculate QALYs gained. This was discounted at
a rate of 3.5% per year of life expectancy to reflect
diminishing gain with age.
Work status and length of postoperative sickness
absence were recorded at follow-up. Further magnetic
resonance (MR) scans, reoperations and/or additional
hospital admissions directly related to the same pathology
were recorded.
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Statistical analysis
All analyses reported are as treated. This was identical to
an intention-to-treat analysis, with the exception of one
patient that crossed over from TED to Micro due to video
equipment failure identified during anaesthetic induction.
Data were analysed using SPSS Version 19.0 (SPSS Inc.,
Chicago, IL, USA). Continuous variables were plotted as
histograms to assess normality. Parametric (unpaired
T tests) and non-parametric (Mann–Whitney U) tests were
used to assess continuous variables for significant differ-
ences between TED and Micro. Nominal categorical vari-
ables were assessed using a Chi-square or Fisher’s exact
test. Relative risks were calculated for binary outcomes
(repeat MR scan and revision). Repeated measures
ANOVA was used to examine changes in parametric
variables over the 2-year study period. A p value of\0.05
was considered to be statistically significant. Post hoc
analysis of PROMs changes over time was performed using
paired t tests. The significance level for this was set at
p\ 0.0125 incorporating a Bonferroni correction to cor-
rect for multiple testing.
Results
Of 160 patients with a single-level disc prolapse assessed
for eligibility to this trial, 143 met the inclusion criteria,
who were recruited and randomised to the two treatment
arms (Fig. 1). Three patients randomised to TED did not
undergo any surgery and are not included in the analysis:
one opted for nerve root injection and two underwent
unrelated emergency surgery for other conditions and did
not return for review. An additional patient randomised to
TED underwent Micro due to equipment failure on the day
of surgery. This patient has been included ‘as treated’ in
the Micro group, giving 70 patients in each arm.
Baseline patient characteristics are shown in Table 1.
Length of anaesthesia induction and operative time were
equivalent (Table 2). A single radiographic image was
used for level determination in Micro, thus radiation time
and dosage was less than in TED. The TED group had a
significantly shorter length of hospital stay
(0.7 days ± 0.7, range 0–2 vs 1.4 days ± 1.3, range 0–9,
p\ 0.001).
PROMs
All PROMs improved significantly over the first
3 months following surgery in both groups (p\ 0.001,
ANOVA Table 3; Figs. 2, 3). After Micro, ODI
improved significantly to 1 year (p = 0.03) and VAS on
the side of primary sciatica from 1 to 2 years
(p = 0.005). After TED, ODI improved significantly to
1 year (p = 0.04) and PCS from 1 to 2 years
p = 0.037). The VAS ‘affected’ leg pain score at 2 years
was significantly less following TED (1.9 ± 2.6) than
Micro (3.5 ± 3.1, p = 0.002) (Fig. 2c). Patients were
generally more satisfied after TED (p = 0.03, Fig. 2d).
Complications and revisions
There were no major intra-operative or perioperative
complications in either group. Two TED patients had sig-
nificant headaches immediately postoperatively, possibly
due to dural tears and CSF leakage. Both settled with bed
rest for 12 h. Four TED patients experienced mild
dysaesthesia which settled within 2–4 weeks. One Micro
patient had a persistent foot drop.
The number of additional MR scans and same level
revision procedures performed within 2 years of the index
surgery was higher in the TED group. Repeat MR was
required in 14 TED patients compared to 6 Micro
(p = 0.13, Chi-squared test) giving a relative risk (RR) of
repeat MR scan of 2.67 (95% CI 0.96–7.41). Additional
scans were performed at a mean of 41 ± 18 weeks (range
10–78) following TED and 51 ± 8 weeks (36–59) fol-
lowing Micro (p = 0.104). Revision surgery was required
in 5 TED patients compared to 2 Micro (p = 0.44, Fisher’s
exact test) giving an RR of 2.62 (0.49–14.0). TED patients
underwent revision at 12, 26, 33, 56 and 60 weeks. Four
had insidious recurrence of symptoms and one suffered an
acute same level herniation after violent sneezing. The two
Micro patients were revised at 51 and 60 weeks without
any known new ‘disc insult’.
The TED group utilised fewer physiotherapy sessions
(mean 2.9 ± 4.2 vs 4.2 ± 5.9, p = 0.21) and alternative
therapy sessions (mean 0.3 ± 1.4 vs 0.5 ± 1.8,
p = 0.193). This was not statistically significant.
Quality of life
The SF-6D health-related quality of life measure improved
significantly to 2 years in both groups (Table 4). There was
no significant difference in SF-6D improvement between
groups or in QALYs gained, absolute or discounted
(Table 4). Preoperatively, 116/140 patients (58 TED and
58 Micro) were in employment (Table 1), 12 of whom (7
TED and 5 Micro) worked part time. Forty-two of those in
work required time off preoperatively due to their disc
disease (24 TED and 16 Micro, p = 0.447, Chi square).
Postoperatively, patients returned to work at a median of
2 months in both groups (p = 0.89, Mann–Whitney U).
There was no significant difference in postoperative work
status between groups (p = 0.79, Chi square, Fig. 4). Eight
patients were unable to return to work (4 TED, 4 Micro).
Eur Spine J (2017) 26:847–856 849
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Fig. 1 Consort diagram of patient recruitment and retention
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Discussion
Patient-reported outcomes following TED were not inferior
to those following Micro and some were better. This sup-
ports a previous study comparing outcomes from a cohort
study of TED and Micro data from the Swedish Spine
Registry [20]. Pain in the affected leg was significantly
better in the TED group at 2 years. This is in contrast to the
findings of the 2014 Cochrane Review of all forms of
minimally invasive discectomy (11 studies) that indicated
that patients had less ongoing leg pain following open
discectomy [21]. However, sample sizes were small and
many of the studies were of questionable quality. We found
no difference in back pain between treatments.
Improvements in ODI at 12 months for both TED and
Micro were similar to those reported in the SPORT trial
following Micro [22]. Patient-reported outcomes for TED
were similar to those reported by Ahn et al. [23] in their
recent retrospective analysis of outcomes following endo-
scopic discectomy (Yeung Endoscopic Spine System
technique) in young soldiers.
In this trial, only patients with non-sequestered hernia-
tions are included. Distally migrated discs are amenable to
transforaminal surgery [24] but it is technically difficult.
Inclusion of these patients was thought at the trial outset to
potentially introduce bias. A lower age limit of 25 was
selected to exclude ‘juvenile’ type prolapses which have a
different natural history.
Table 1 Baseline characteristics of the two groups
TED (n = 70) Micro (n = 70) Comparison (p value)
Demographics
Age in years (SD) 42 (9) 39 (9) 0.76*
Age range 26–69 25–69
Female (%) 40 (57) 30 (43) 0.09a
Weight in kilograms (SD) 76 (17) 81 (17) 0.95*
Weight range 45–108 45–115
Smoker (%) 30 (43) 20 (29) 0.11a
Median symptom duration in months (range) 18 (4–120) 15 (3–120) 0.54**
Employment status
Employed (%) 58 (83) 58 (83) 0.32a
Unemployed (%) 5 (7) 4 (6
Retired (%) 4 (6) 1 (1)
Unknown (%) 3 (4) 7 (10)
PROMs
ODI (SD) 44 (17) 42 (15) 0.58*
VAS Back (SD) 5.7 (2.7) 4.6 (2.7) 0.58*
VAS Affected Leg (SD) 6.2 (2.8) 5.8 (2.6) 0.57*
VAS Non-affected Leg (SD) 1.0 (1.8) 0.7 (1.3) 0.29**
SF-36 PCS (SD) 34.1 (6.8) 35.7 (7.1) 0.20*
SF-36 MCS (SD) 38.1 (13.1) 37.9 (12.4) 0.91*
Surgical level
L3/4 (%) 0 (0) 2 (3) 0.05a
L4/5 (%) 32 (46) 21 (30)
L5/S1 (%) 38 (54) 47 (67)
Disc position
Central 19 (27) 17 (24) 0.88a
Lateral 38 (54) 39 (56)
Foraminal 10 (14) 12 (17)
Extraforaminal 3 (4) 2 (3)
Data are mean (standard deviation), median (range) or number (%) as stated
* Unpaired T test
** Mann–Whitney U
a Chi-squared
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Symptom duration prior to surgery displayed a broad
range. Sub-analysis of the SPORT trial [22] has indicated
that patients with greater than 6 months of symptoms risk
inferior results. Most of our patients reported a history of
some symptoms at a mean of 2 years before surgery and
we were not able to discriminate ‘acute’ symptoms with
Table 2 Surgical outcome data
TED (n = 70) Micro (n = 70) Comparison (p value)
Hospital stay in nights (SD) 0.7 (0.7) 1.4 (1.3) \0.001**
Hospital stay range 0–2 0–9
Anaesthesia and set-up in minutes (SD) 28 (11) 29 (12) 0.81*
Incision to closure in minutes (SD) 61 (16) 65 (36) 0.94*
Radiation dose in cGy cm2 (SD) 574 (287) 40 (31) \0.001**
Radiation time in minutes (SD) 0.98 (0.45) 0.05 (0.09) \0.001**
Number revised by 2 years (%) 5 (7) 2 (3) 0.44***
Time to revision in weeks (SD) 46 ± 16 60 ± 1 0.02**
Means (standard deviation), number (%)
* Unpaired T test
** MannWhitney U test
*** Fisher’s exact test
Table 3 Postoperative patient-
reported outcome measures
TED (n = 70) Micro (n = 70) Comparison (p value)
ODI
3 months (SD) 27(18) 27 (18) 0.84**
1 year (SD) 22 (20) 22 (19) 0.95**
2 years (SD) 18 (17) 22 (20) 0.15**
VAS back
3 months (SD) 3.0 (2.7) 3.1 (2.9) 0.66**
1 year (SD) 3.1 (3.1) 3.1 (2.7) 0.67**
2 years (SD) 2.5 (2.5) 3.0 (2.8) 0.45**
VAS affected leg
3 months (SD) 2.8 (2.9) 3.2 (3.2) 0.45**
1 year (SD) 2.6 (3.1) 2.7 (2.8) 0.54**
2 years (SD) 1.9 (2.6) 3.5 (3.1) 0.001**
VAS non-affected leg
3 months (SD) 0.3 (0.9) 0.5 (1.4) 0.04**
1 year (SD) 0.5 (1.7) 0.7 (1.8) 0.11**
2 years (SD) 0.6 (1.5) 0.8 (1.8) 0.43**
SF-36 PCS
3 months (SD) 42.4 (9.6) 43.1 (8.6) 0.65*
1 year (SD) 45.0 (10.9) 45.1 (10.8) 0.97**
2 years (SD) 47.7 (10.6) 47.4 (10.6) 0.69**
SF-36 MCS
3 months (SD) 44.6 (14.2) 43.7 (14.4) 0.68**
1 year (SD) 47.9 (14.8) 44.8 (13.9) 0.13**
2 years (SD) 49.4 (14.1) 45.2 (14.8) 0.06**
Mean (standard deviation)
ODI Oswestry Disability Index, VAS Visual Analogue Scale for pain, PCS physical component score, MCS
mental component score
* Unpaired T test
** Mann–Whitney U test
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accuracy. However, symptom duration was similar in both
groups. Once in contact with the surgical service, the
preoperative rehabilitation regime was standardised for all
patients. We cannot comment on the effect or nature of any
other prior non-operative management. Following surgery,
patients were referred for physiotherapy if they complained
of stiffness. Alternative therapies were not prescribed, but
if received, were sourced independently by the patient and
may represent a possible source of bias between groups.
We recognise that anaesthetic methods differed between
the treatment arms in this trial with conscious sedation
rather than GA chosen for TED as a ‘patient reporting’
safeguard against nerve root injury. Although the
difference in anaesthesia did not materially alter the length
of the surgical procedure (the longer GA induction for the
Micro group was balanced by a longer theatre ‘set-up’ time
for TED) it should be accepted that a shorter ‘wake-up’
after surgery would have contributed to the reduced hos-
pital stay noted in the TED group. This difference may not
have been as pronounced if GA had been used in both
groups. Radiation doses for both procedures were well
within safe ranges (\3% of accepted Dose Area Product
threshold of 500 Gy cm2) [25].
The site of disc prolapse was similarly distributed in
both treatment arms. The transforaminal approach is par-
ticularly suited to excision of ‘far-out’ prolapse and
Fig. 2 Patient-reported outcome measures a Oswestry Disability Index (ODI), b Visual Analogue Scale (VAS) for back pain, c VAS for leg
pain, d Odom’s criteria
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widening of the foramen for the exiting nerve root [26]. In
contrast, Micro provides easier access to the lateral recess
of the canal, although possibly with greater epidural scar-
ring [27]. Access to the L5/S1 disc during TED may be
difficult if the patient’s pelvic crest is high. In this series,
L5/S1 disc access was facilitated by careful patient posi-
tioning using a ‘broken’ operating table and no patient
required intra-operative conversion to Micro.
Transforaminal endoscopic surgery is associated with a
significant learning curve [28]. All five revisions in the
TED arm of the trial were within the first two-thirds of the
study. As surgical experience with TED increases and
technology advances, the incidence of revision would be
expected to decline.
The combined rate of revision surgery at 5% was within
that expected from most reported studies of discectomy. Of
those revised, five opted for Micro as a second operation.
One patient chose to have repeat TED achieving a good
outcome. The reported absence of scarring at revision of
Fig. 3 SF-36 scores a physical component score (PCS) and b mental component score (MCS)
Table 4 Health-related quality
of life
TED (n = 70) Micro (n = 70) Comparison (p value)
SF-6D
Preoperative (SD) 0.534 (0.09) 0.531 (0.09) 0.88*
1 year (SD) 0.666 (0.16) 0.670 (0.15) 0.97**
2 years (SD) 0.693 (0.18) 0.689 (0.16) 0.39**
QALYs gained at 2 years: absolute (SD) 5.944 (6.6) 6.041 (7.1) 0.95*
QALYs gained at 2 years: discounted (SD) 1.640 (1.7) 1.412 (1.5)
Mean (standard deviation)
QALYs quality-adjusted life years
* Unpaired T test
** Mann–Whitney U test
Fig. 4 Return to work status. Negative changes include reduced
working hours or an inability to work due to disc disease. Positive
changes include an increase in working hours or re-employment
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TED [29] has important implications for longer-term out-
comes in terms of the ease of revision surgery. The
reduction in tissue disruption provided by the TED tech-
nique may also have important effects on outcome via a
reduction in cytokine release lessening the overall inflam-
matory response to surgery [30]. In this trial, patients who
underwent revision were included in our outcome data only
up to the point of revision. This point was considered to
represent their worst outcome scores as all patients
improved following revision surgery. Had outcome scores
subsequent to revision procedures been included this may
have falsely improved 1 and 2 year results. On this basis,
we found no significant difference in quality of life
improvement between the treatment arms at 2 years.
Weaknesses of this study include the non-blinded nature
of the trial. Both surgeon and patient were aware of their
treatment and the senior surgeon acknowledges a specific
interest in endoscopy which may introduce bias. However,
all outcomes were collected independently and are patient
reported. The data were scrutinised by all authors. Differ-
ent anaesthetic techniques were used which may favour
shorter length of stay in the TED group. This was prag-
matic as it was considered safer to perform TED under
conscious sedation. Though length of stay was significantly
shorter in the TED group, this was a secondary outcome
measure and the study was not powered to detect differ-
ences therein. No record was made of any litigation per-
taining to any presenting injury. Finally, data were
analysed ‘‘as treated’’ not as ‘‘intention-to-treat’’. This was
considered acceptable as only one case crossed over
between treatment arms and this was due to equipment
failure not clinical choice. Thirteen patients (9.3%) were
lost to follow-up by 2 years. This was within the 10%
allowed by our power calculation and was significantly less
than the 20% required by a level 1 trial.
Conclusions
Transforaminal endoscopic discectomy and microdiscec-
tomy give comparable outcomes. A reduced length of
hospital stay and less leg pain at 2 years following TED are
offset by a greater requirement for repeat MR scans and
revision surgery. Although a learning curve applies for this
technique, the lack of requirement for general anaesthesia
and a mean length of stay under 1 day makes TED an ideal
technique for use in day-case units.
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